Clinical Trial Update: Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the combination of trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic breast cancer that progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED